Effects of estrogen on cell cycle progression and associated metabolic pathways in normal and tumorigenic breast cells

Signal Transduction

Volumn 3, Issue 1-2, 2003, Pages 9-16

  Hass, Ralf ^a   Sohn, Christof ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

20S proteasome; Breast cancer; Cell cycle; Estrogen; Matrix metalloproteinase; Proliferation

Indexed keywords

ESTRADIOL; ESTROGEN; GELATINASE B; INTERSTITIAL COLLAGENASE; MANGANESE SUPEROXIDE DISMUTASE; MATRILYSIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEASOME;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL ADHESION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL METABOLISM; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESTROGEN ACTIVITY; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0242443868     PISSN: 16154053     EISSN: None     Source Type: Journal    
DOI: 10.1002/sita.200300021     Document Type: Article

References (25)

1. Alberg, A. J., Lam, A. P., Helzlsouer, K. J. (1999) Epidemiology, prevention, and early detection of breast cancer. Curr. Opin. Oncol. 1: 435-441.
2. Sturek-Ware, R. (2002) Hormonal replacement therapy. Rev. Endocr. Metab. Disorders 3: 243-256.
3. Henderson, I. C. (1993) Risk factors for breast cancer development. Cancer 71: 2127-2140.
4. Kelsey, J. L., Bernstein, L. (1996) Epidemiology and prevention of breast cancer. Annu. Rev. Public Health 17: 47-67.
5. Soule, H. D., Vazquez, J., Long, A., Albert, S., Brennan, M. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51: 1409-1416.
6. Keydar, I., Chen, L., Karby, S., Weiss, F.R., Delarea, J., Radu, M., Chaitcik, S., Brenner, H.J. (1979) Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer 15: 659-670.
7. McManus, M. J., Welsch, C. W. (1981) Hormone-induced ductal DNA synthesis of human breast tissues maintained in the athymic nude mouse. Cancer Res. 41: 3300-3305.
8. Ullrich, O., Reinheckel, T., Sitte, N., Hass, R., Grune, T., Davies, K. (1999) Poly-ADP-ribose-polymerase activates nuclear proteasome to degrade oxidatively-damaged histones. Proc. Natl. Acad. Sci. USA 96: 6223-6228.
9. Russo, J., Russo, I. H. (1999) Cellular basis of breast cancer susceptibility. Oncol. Res. 11: 169-178.
10. Service RF. (1998) New role for estrogen in cancer? Science 279: 1631-1633.
11. Bergstraesser, L. M., Weitzman, S. A. (1993) Culture of normal and malignant primary human mammary epithelial cells in a physiological manner simulates in vivo growth patterns and allows discrimination of cell type. Cancer Res. 3: 2644-2654.
12. Smith, L. M., Birrer, M. J., Stampfer, M. R., Brown, P. H. (1997) Breast cancer cells have lower activating protein 1 transcription factor activity than normal mammary epithelial cells. Cancer Res. 57: 3046-3054.
13. Russo, J., Russo, I. H. (1997) Role of hormones in human breast development: the menopausal breast. In: Progress in the management of the menopause. Ed. Wren, B. G., Parthenon, New York-London.
14. Small, R., Friedman, G. D., Ettinger, B. (2002) Concomitant medication use in postmenopausal woming using estrogen therapy. Menopause 8: 120-126.
15. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
16. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., Gustafsson, J.A. (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93: 5925-5930.
17. Xu, J., O'Malley, B. W. (2002) Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function. Rev. Endocr. Metab. Disorders 3: 185-192.
18. Glass, C. K., Rosenfeld, M. G. (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14: 121-141.
19. Ciana, P., Raviscioni, M., Mussi, P., Vegeto, E., Que, I., Parker, M. G., Lowik, C., Maggi, A. (2003) In vivo imaging of transcriptionally active estrogen receptors. Nature Med. 9: 82-86.
20. Prudovsky, I., Popov, K., Akimov, S., Serov, S., Zelenin, A., Meinhardt, G., Baier P., Sohn, C., Hass, R. (2002) Antisense CD11b integrin inhibits the development of a differentiated monocyte/macrophage phenotype in human leukemia cells. Eur. J. Cell Biol. 81: 36-42.
21. Ali, S., Metzger, D., Bornert, J. M., Chambon, P. (1993) Modulation of transcriptional activation by ligand-dependent phosphorylation of the human estrogen receptor A/B region. EMBO J. 12: 1153-1160.
22. Chen, D., Riedl, T., Washbrook, E., Pace, P. E., Coombes, R. C., Egly, J.-M., Ali, S. (2000) Activation of estrogen receptorα by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Molecular Cell 6: 127-137.
23. Molinari, M. (2000) Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 33: 261-274.
24. Ullrich, O., Ciftci, Ö., Hass, R. (2000) Proteasome activation by poly-ADP-ribose-polymerase in human myelomonocytic cells after oxidative stress. Free Radical Biol. Med. 29: 995-1004.
25. Ciftci, Ö., Ullrich, O., Schmidt, C., Diestel, A., Hass, R. (2001) Regulation of the nuclear proteasome activity in myelomonocytic human leukemia cells after adriamycin treatment. Blood 97: 2830-2838.